AVR Anteris Technologies Global Corp.

BEARISH Impact: 6/10 424B5
Horizon weeks Filed May 22, 2026 Processed 18d 10h ago SEC 0001140361-26-022632
Notable filing: 424B5
Latest settled — T+5d
AVR ▲ +2.31% at T+5d
SHORT call ✗ call lost -2.31% · α vs SPY -1.10% · entry $9.08 → $9.29
Next anchor: T+20d in 13d
Last close $9.34 (close Jun 8) · -2.86% from $9.08 entry (call sign-flipped)
Entry anchored
May 22, 2026
via day open
T+1d
-2.42%
call +2.42% · α +2.44%
$8.86
settled 15d ago
T+5d
+2.31%
call -2.31% · α -1.10%
$9.29
settled 9d ago
T+20d
call — · α —
in 13d
T+60d
call — · α —
in 2mo

Price Chart

Loading chart...

Executive Summary

Anteris Technologies Global Corp. filed a 424B5 prospectus supplement for an at-the-market (ATM) offering of up to $250 million of common stock through TD Cowen. The proceeds will primarily fund ongoing development of the DurAVR THV System. At the assumed price of $9.00/share, the offering would represent ~28.5% dilution relative to current market cap, with immediate dilution of $4.84/share for new investors.

Actionable Insight

The large ATM overhang will likely pressure the stock near-term. Monitor sales pace via quarterly disclosures; heavy selling could cap upside. Positive PARADIGM trial milestones may offset dilution, but the certainty of future equity issuance is a headwind.

Key Facts

  • ATM offering up to $250,000,000 of common stock via TD Cowen
  • 3.0% commission on gross proceeds to TD Cowen
  • Proceeds to fund DurAVR THV System development and general corporate purposes
  • Immediate dilution of $4.84 per share at assumed $9.00 price (55% of offering price)
  • 97,232,054 shares outstanding as of March 31, 2026; up to 27,777,777 new shares (28.6% dilution) at $9.00
  • Stock closed at $9.00 on May 21, 2026; market cap ~$876M

Financial Impact

Up to $250M gross proceeds with 3% underwriting fee; immediate dilution of $4.84 per share (55% of offering price) for new investors

dilution

Risk Factors

  • Significant dilution to existing shareholders
  • ATM sales may occur at prices below $9.00, increasing dilution
  • Potential further equity offerings if cash runway needs extend
  • Market overhang from large registered shares (including ~15.65M from Jan 2026 PIPE)

Market Snapshot

Exchange
Nasdaq
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
89% bullish (9 analysts)

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0001140361-26-022632
Document: ny20074564x1_ex107.htm0001140361-26-022632
Document: 0001140361-26-022632-index-headers.html0001140361-26-022632
Document: 0001140361-26-022632-index.html0001140361-26-022632
Document: 0001140361-26-022632.txt0001140361-26-022632
5 reports for AVR
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for AVR — sortable, filterable
Type Now
Jun 4, 2026
5d ago
Insider Buy
BULLISH ★ 4/10
$9.65 awaiting T+5awaiting T+5$9.34 (−3.21%)
May 22, 2026
18d ago
424B5
BEARISH ★ 6/10
$9.08 $9.29▼ −2.31%▼ −1.10%$9.34 (−2.86%)
May 12, 2026
28d ago
Press Release
BEARISH ★ 7/10
$6.53 $7.70▼ −17.92%▼ −19.08%$9.34 (−43.03%)
Mar 16, 2026
12w ago
EFFECT
NEUTRAL ★ 4/10
$6.27 $5.47▼ −12.76%▼ −10.72%$9.34 (+48.96%)
Feb 27, 2026
14w ago
8-K
BEARISH ★ 7/10
$6.51 $6.20▲ +4.76%▲ +2.78%$9.34 (−43.47%)
Showing 5 of 5

US Market Status

Market Closed — Opens in 6h 6m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access